68 related articles for article (PubMed ID: 12116055)
1. Cardiac status in bone tumor survivors up to nearly 19 years after treatment with doxorubicin: a longitudinal study.
Postma A; Elzenga NJ; Haaksma J; Schasfoort-Van Leeuwen MJ; Kamps WA; Bink-Boelkens MT
Med Pediatr Oncol; 2002 Aug; 39(2):86-92. PubMed ID: 12116055
[TBL] [Abstract][Full Text] [Related]
2. Late cardiotoxicity after treatment for a malignant bone tumor.
Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiac follow-up in survivors of a malignant bone tumour.
Brouwer CA; Gietema JA; van den Berg MP; Bink-Boelkens MT; Elzenga NJ; Haaksma J; Kamps WA; Vonk JM; de Vries EG; Postma A
Ann Oncol; 2006 Oct; 17(10):1586-91. PubMed ID: 16857723
[TBL] [Abstract][Full Text] [Related]
4. Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?
Pourier MS; Mavinkurve-Groothuis AM; Loonen J; Bökkerink JP; Roeleveld N; Beer G; Bellersen L; Kapusta L
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654133
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
[TBL] [Abstract][Full Text] [Related]
6. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
7. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
[TBL] [Abstract][Full Text] [Related]
8. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
[TBL] [Abstract][Full Text] [Related]
9. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term music therapy intervention on autonomic function in anthracycline-treated breast cancer patients.
Chuang CY; Han WR; Li PC; Song MY; Young ST
Integr Cancer Ther; 2011 Dec; 10(4):312-6. PubMed ID: 21382955
[TBL] [Abstract][Full Text] [Related]
12. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents].
Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G
Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932
[TBL] [Abstract][Full Text] [Related]
13. Subclinical late cardiac toxicity in childhood cancer survivors: impact on self-reported health.
Cox CL; Rai SN; Rosenthal D; Phipps S; Hudson MM
Cancer; 2008 Apr; 112(8):1835-44. PubMed ID: 18311782
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
15. Cardiac toxicity 4 to 20 years after completing anthracycline therapy.
Steinherz LJ; Steinherz PG; Tan CT; Heller G; Murphy ML
JAMA; 1991 Sep; 266(12):1672-7. PubMed ID: 1886191
[TBL] [Abstract][Full Text] [Related]
16. Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters.
Mladosievicova B; Foltinova A; Petrasova H; Hulin I
Int J Mol Med; 2000 Apr; 5(4):411-4. PubMed ID: 10719059
[TBL] [Abstract][Full Text] [Related]
17. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
[TBL] [Abstract][Full Text] [Related]
18. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B
J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.
Bossi G; Lanzarini L; Laudisa ML; Klersy C; Raisaro A; Aricò M
Med Pediatr Oncol; 2001 Jun; 36(6):593-600. PubMed ID: 11344489
[TBL] [Abstract][Full Text] [Related]
20. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography.
Lenk MK; Zeybek C; Okutan V; Ozcan O; Gökçay E
Turk J Pediatr; 1998; 40(3):373-83. PubMed ID: 9763901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
